BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7556169)

  • 1. Intracellular levels and secretion of insulin-like-growth-factor-binding proteins in MCF-7/6, MCF-7/AZ and MDA-MB-231 breast cancer cells. Differential modulation by estrogens in serum-free medium.
    Dubois V; Couissi D; Schonne E; Remacle C; Trouet A
    Eur J Biochem; 1995 Aug; 232(1):47-53. PubMed ID: 7556169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
    Juncker-Jensen A; Lykkesfeldt AE; Worm J; Ralfkiaer U; Espelund U; Jepsen JS
    Growth Horm IGF Res; 2006 Aug; 16(4):224-39. PubMed ID: 16893667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitro.
    McCotter D; van den Berg HW; Boylan M; McKibben B
    Cancer Lett; 1996 Feb; 99(2):239-45. PubMed ID: 8616830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status.
    Clemmons DR; Camacho-Hubner C; Coronado E; Osborne CK
    Endocrinology; 1990 Dec; 127(6):2679-86. PubMed ID: 1701124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.
    Martin JL; Coverley JA; Pattison ST; Baxter RC
    Endocrinology; 1995 Mar; 136(3):1219-26. PubMed ID: 7532580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of insulin-like growth factor binding proteins in breast cancer cells.
    Yee D; Favoni RE; Lippman ME; Powell DR
    Breast Cancer Res Treat; 1991 Mar; 18(1):3-10. PubMed ID: 1713084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and insulin modulation of intracellular insulin-like growth factor binding proteins in human breast cancer cells: possible involvement in lysosomal hydrolases oversecretion.
    Dubois V; Couissi D; Schonne E; Schneider YJ; Remacle C; Trouet A
    Biochem Biophys Res Commun; 1993 Apr; 192(1):295-301. PubMed ID: 7682810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.
    Couissi D; Dubois V; Remacle C; Schonne E; Trouet A
    Clin Exp Metastasis; 1997 Jul; 15(4):349-60. PubMed ID: 9219723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and regulation of insulin-like growth factor binding proteins produced by hormone-dependent and -independent human breast cancer cell lines.
    Kim I; Manni A; Lynch J; Hammond JM
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):71-8. PubMed ID: 1718794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
    McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
    J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line.
    Adamo ML; Shao ZM; Lanau F; Chen JC; Clemmons DR; Roberts CT; LeRoith D; Fontana JA
    Endocrinology; 1992 Oct; 131(4):1858-66. PubMed ID: 1382963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780.
    Huynh H; Yang XF; Pollak M
    Cell Growth Differ; 1996 Nov; 7(11):1501-6. PubMed ID: 8930399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro.
    Camacho-Hubner C; McCusker RH; Clemmons DR
    J Cell Physiol; 1991 Aug; 148(2):281-9. PubMed ID: 1715344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
    Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
    J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media.
    Pratt SE; Pollak MN
    Cancer Res; 1993 Nov; 53(21):5193-8. PubMed ID: 7693333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the secretion of insulin-like growth factor binding proteins -2 and -4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines.
    Maxwell P; van den Berg HW
    Cancer Lett; 1999 May; 139(2):121-7. PubMed ID: 10395168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells.
    Auernhammer CJ; Fottner C; Engelhardt D; Bidlingmaier M; Strasburger CJ; Weber MM
    Horm Res; 2002; 57(1-2):15-21. PubMed ID: 12006714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.